#BreakingNews We’ve received U.S. FDA accelerated approval for the first engineered cell therapy for the treatment of a solid tumor cancer. #CellTherapy #Biotech #Innovation #Oncology #CancerCare Press Release Link: https://lnkd.in/gp68yd6U
Adaptimmune
Biotechnology Research
Abingdon, Oxfordshire 49,525 followers
Designing and delivering cell therapies to transform the lives of people with cancer.
About us
Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page.
- Website
-
http://www.adaptimmune.com
External link for Adaptimmune
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Abingdon, Oxfordshire
- Type
- Public Company
- Founded
- 2008
Locations
-
Primary
60 Jubilee Avenue
Milton Park
Abingdon, Oxfordshire OX14 4RX, GB
-
351 Rouse Boulevard
Philadelphia, Pennsylvania 19112, US
-
100 Binney St
Suite 710
Cambridge, Massachusetts 02142, US
Employees at Adaptimmune
Updates
-
Our CFO, Gavin Wood, shares his leadership philosophy. What’s yours? #CancerResearch #CellTherapy #Oncology #ServantLeadership www.adaptimmune.com
-
What aspects of a company culture keep a biotech team engaged and inspired? William Bertrand, our COO, shares the recipe that has kept him and the Adaptimmune team energized to innovate for people with cancer. #CancerResearch #CellTherapy #Oncology #Adaptimmune #Biotech #Innovation www.adaptimmune.com
-
We’re proud to be a sponsor of Ovarian Cancer Research Alliance’s International Gynecologic Cancer Conference starting tomorrow, featuring 25+ online sessions packed with research updates and more: bit.ly/GynCancerConf #CancerResearch #GynecologicCancer
-
Developing cell therapies is a complex challenge, particularly during a global pandemic. Join Dennis Williams, our Senior Vice President of Late-Stage Development, as he shares how we navigate complexity to advance clinical trials such as SPEARHEAD-1. Learn more at www.adaptimmune.com #CancerTherapy #CellTherapy #Oncology #Biotech #Manufacturing
-
Exciting news! 🎉 Our very own John Lunger, Cintia Piccina, and Mark Stielow spoke at the CAR-TCR Summit last week in Boston, MA. They shared their insights into patient supply, commercial strategies, and manufacturing operations in the cell therapy space. #CARTCRSummit #Adaptimmune #CellTherapy #Innovation #Leadership For more details on the event, visit: https://lnkd.in/efyPeGWf
-
🏃♂️🏁 Team Adaptimmune laced up for Sarcoma Foundation of America’s Race to Cure Sarcoma in Philadelphia this past weekend to support synovial sarcoma research and raise funds and awareness for an amazing cause. Our CEO Adrian (Ad) Rawcliffe kicked off the race with opening statements. There are a few more races left for 2024 - sign up for one in your area: https://lnkd.in/ehvFnZE #CureSarcoma #RaceforaCure
-
We are leading the charge and redefining the treatment of solid tumor cancers. Learn how: https://lnkd.in/gTQPUZhw #CancerTreatment #SolidTumors #Adaptimmune #CancerCare
-
#ICYMI: Miltenyi Biotec is approved to manufacture lentiviral vector for Adaptimmune’s first commercial product. We are excited to continue our strong collaboration with Miltenyi as we bring this groundbreaking new cell therapy to patients in the commercial setting. Read more here: https://ow.ly/ai4p50TjQpx
-
#ICYMI This morning, We participated in a fireside chat at the H.C. Wainwright & Co., LLC 26th Annual Global Investment Conference in NYC. Be sure to catch the limited-time recording at https://lnkd.in/gzsPzuTG #Biotech #Innovation #CellTherapy #HCWainwrightGlobal